In vivo cell-mediated immunity in subjects with undetectable viral load on protease inhibitor-based versus non-protease inhibitor-based highly active antiretroviral therapy

J Acquir Immune Defic Syndr. 2003 Apr 15;32(5):570-2. doi: 10.1097/00126334-200304150-00016.
No abstract available

Publication types

  • Clinical Trial
  • Letter

MeSH terms

  • Anti-HIV Agents / therapeutic use*
  • Antiretroviral Therapy, Highly Active*
  • Cross-Sectional Studies
  • HIV Infections / drug therapy*
  • HIV Infections / immunology
  • HIV Protease Inhibitors / therapeutic use*
  • HIV-1 / immunology
  • Humans
  • Hypersensitivity, Delayed
  • Immunity, Cellular
  • Prospective Studies
  • RNA, Viral / blood
  • Viral Load

Substances

  • Anti-HIV Agents
  • HIV Protease Inhibitors
  • RNA, Viral